Facilitated subcutaneous immunoglobulin 10% at a target dose of 0.4 g/kg/infusion is well tolerated with accelerated or no dose ramp-up in healthy participants

Zhaoyang Li, Leman Yel, Noor M. Khaskhely et al.|Clinical Immunology|2023

Cited by 1